Karunatilake Chulani's most recent trade in Werewolf Therapeutics Inc was a trade of 153,129 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Werewolf Therapeutics Inc | Chulani Karunatilake | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 153,129 | 153,129 | - | - | Stock Option (right to buy) | |
| Werewolf Therapeutics Inc | Chulani Karunatilake | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
| Werewolf Therapeutics Inc | Karunatilake Chulani | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
| Werewolf Therapeutics Inc | Chulani Karunatilake | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 103,600 | 103,600 | - | - | Stock Option (right to buy) | |
| Werewolf Therapeutics Inc | Chulani Karunatilake | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 136,000 | 136,000 | - | - | Stock Option (right to buy) | |
| Werewolf Therapeutics Inc | Chulani Karunatilake | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2022 | 34,258 | 34,258 | - | - | Stock Option (right to buy) | |
| Werewolf Therapeutics Inc | Chulani Karunatilake | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 272,000 | 272,000 | - | - | Stock Option (right to buy) |